Gubra A/S
Biotechnology · Healthcare
1 appearance
Latest appearance 2026-08-20
Thomas
Gubra A/S
Equibles does not estimate personal net worth.
About Thomas
Thomas has spoken on 1 earnings call across 1 company, most recently for Gubra A/S on August 20, 2026. Gubra A/S is classified in the Biotechnology industry within the Healthcare sector.
Thomas on recent calls
“So now let me turn to what makes GOOC-UCN2 so compelling. So GOOC-UCN2 is a long-acting agonist at the CRHR2 receptor, and that makes it really a very differentiated and novel mechanism of action that addresses key needs for people living with obesity.”
Affiliation history
-
Gubra A/S
Transcript header (unverified)
Current
Company network
Recent activity
-
Earnings call
Gubra Q2 2026
Gubra A/S